These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33990058)

  • 21. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
    Bernard CL; Owens DK; Goldhaber-Fiebert JD; Brandeau ML
    PLoS Med; 2017 May; 14(5):e1002312. PubMed ID: 28542184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.
    Spiller MW; Broz D; Wejnert C; Nerlander L; Paz-Bailey G; ;
    MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(10):270-5. PubMed ID: 25789742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan.
    Capelastegui F; Trickey A; Thompson LH; Reza T; Emmanuel F; Cholette F; Blanchard JF; Archibald C; Vickerman P; Lim AG
    Pathog Glob Health; 2023 Dec; 117(8):696-707. PubMed ID: 36950726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.
    Prata Menezes NS; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS
    J Int AIDS Soc; 2024 Apr; 27(4):e26241. PubMed ID: 38632848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015.
    Whiteman A; Burnett J; Handanagic S; Wejnert C; Broz D;
    Int J Drug Policy; 2020 Nov; 85():102923. PubMed ID: 32920424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.
    Tempalski B; Williams LD; West BS; Cooper HLF; Beane S; Ibragimov U; Friedman SR
    Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):3. PubMed ID: 31918733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
    Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
    Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
    Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z
    PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a global index measuring national policy commitments to HIV prevention and treatment among people who inject drugs.
    Sevigny EL; Meylakhs P; Feizollahi MJ; Amini MR
    Int J Drug Policy; 2020 Oct; 84():102877. PubMed ID: 32717705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
    Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
    Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
    Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use.
    Adams M; Sionean C; Broz D; Lewis R; Wejnert C;
    J Infect Dis; 2020 Sep; 222(Suppl 5):S401-S409. PubMed ID: 32877554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, implementation, and monitoring of HIV service packages for people who inject drugs: An assessment of programs supported by the Global Fund in 46 countries.
    Burrows D; Falkenberry H; McCallum L; Parsons D; Ngoksin E; Zhao J; Kunii O
    Int J Drug Policy; 2021 Feb; 88():103036. PubMed ID: 33212370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.
    Allen ST; White RH; O'Rourke A; Schneider KE; Weir BW; Lucas GM; Kilkenny ME; Sherman SG
    AIDS Behav; 2021 Oct; 25(10):3377-3385. PubMed ID: 33886011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
    Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
    Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012.
    Cooley LA; Wejnert C; Spiller MW; Broz D; Paz-Bailey G;
    Drug Alcohol Depend; 2016 Aug; 165():270-4. PubMed ID: 27323649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
    Allen S; Ruiz M; O'Rourke A
    Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
    Tempalski B; Lieb S; Cleland CM; Cooper H; Brady JE; Friedman SR
    J Urban Health; 2009 Jan; 86(1):132-54. PubMed ID: 19015995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.